Luppino

Luppino is the founder and CEO of Remedium Bio, a Boston-area pre-clinical stage gene therapy company. They also serve as President of BioSource CXO, providing regulatory approval strategy, clinical program design, operations management, product development, and business development to life science companies. Luppino has over 25 years of experience in device, drug, and biologic development, manufacturing, and regulatory compliance, including leadership roles at Anika Therapeutics as Vice President of Operations and Chief Operating Officer, at Bionostics as Vice President of Operations, and in engineering and validation capacities at Raytheon Engineers & Constructors and Black & Veatch. They studied at Lehigh University from 1986 to 1990.